Ensysce Biosciences (ENSC) vs Rocket One (RKTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Rocket One is the larger company by market cap ($7.4 million vs $7.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENSC | RKTO |
|---|---|---|
| Share price | $0.36 | $0.297 |
| Market cap | $7.00M | $7.39M |
| 1-day change | -0.17% | +5.24% |
| YTD return | — | -70.00% |
| 1-year return | — | -72.63% |
| 5-year return | — | -98.60% |
| EPS (TTM) | $-7.51 | $-0.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.07M | — |
| Revenue growth (YoY) | -2.75% | — |
| Net income (latest FY) | $-10.18M | $-12.47M |
| Operating margin | -202.12% | — |
| Net margin | -200.85% | — |
| 52-week high | $1.85 | $2.45 |
| 52-week low | $0.23 | $0.26 |
| Distance from 52-week high | -80.54% | -87.88% |
| Analyst consensus | none | — |
| Avg. price target upside | +2191.67% | — |
| Average volume | 493.43K | 338.12K |
| Shares outstanding | 19.46M | 24.90M |
| Employees | 8 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Ensysce Biosciences
ENSC stock →Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
About Rocket One
RKTO stock →Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
ENSC vs RKTO FAQ
Which is bigger, Ensysce Biosciences or Rocket One?
Rocket One (RKTO) is larger, with a market capitalization of $7.39M compared with $7.00M for Ensysce Biosciences (ENSC).
Are Ensysce Biosciences and Rocket One in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.